BMP4 and neoplasm: BMP4 has shown some promise as a potential targeted therapy for GSCs, inducing differentiation of GSCs - increasing radiosensitivity and reducing overall tumor burden in in vitro and in animal studies (32,33), and recently has been shown to be safe in a phase I clinical trial (37).